COYA 303 is an investigational proprietary combination of LD-IL-2 and GLP-1RA for subcutaneous administration, under development for the treatment of diseases, including Alzheimer's Disease, driven by ...
To conduct research requiring cell culture work and to perform fundamental cell culture protocols, there are several key pieces of equipment and some basic reagents that are required, summarized in ...